(Q34415972)

2 August 2017

1 reference

title

Hemoglobin catabolism and iron utilization by malaria parasites (English)

1 reference

2 August 2017

0 references

Rosenthal PJ

1

1 reference

PubMed ID

9027746

2 August 2017

Meshnick SR

series ordinal

2

1 reference

2 August 2017

1 December 1996

1 reference

Molecular and Biochemical Parasitology

2 August 2017

1 reference

2 August 2017

83

1 reference

2 August 2017

131-139

1 reference

2 August 2017

2

1 reference

The proteases and pathogenicity of parasitic protozoa

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Mitochondria of mammalian Plasmodium spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Iron chelation therapy for malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Inability to detect transferrin receptors on P. falciparum parasitized red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Parasite uptake of desferroxamine: a prerequisite for antimalarial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Deferoxamine inhibition of malaria is independent of host iron status

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemoglobin denaturation and iron release in acidified red blood cell lysate--a possible source of iron for intraerythrocytic malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Stage-Dependent Effects of Chloroquine onPlasmodium falciparumIn Vitro1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

The plasmodium digestive vacuole: metabolic headquarters and choice drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Antimalarials increase vesicle pH in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Effects of antimalarials and protease inhibitors on plasmodial hemozoin production

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Plasmodium falciparum: protease inhibitors and inhibition of erythrocyte invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemin lyses malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Haemozoin and the mode of action of blood schizontocides: more controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

The composition of haemozoin from Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Haem polymerization in malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Plasmodium hemozoin formation mediated by histidine-rich proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Iron regulatory elements (IREs): a family of mRNA non-coding sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates--a possible mechanism of their anti-malarial effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Arteether, a new antimalarial drug: synthesis and antimalarial properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

The interaction of artemisinin with malarial hemozoin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Reaction of antimalarial endoperoxides with specific parasite proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Patterns of haemozoin accumulation in tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

In vitro antimalarial activity of chalcones and their derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2896%2902763-6

7 January 2021

10.1016/S0166-6851(96)02763-6

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

9027746